|
1
|
Zanetti M, Gennaro R, Scocchi M and
Skerlavaj B: Structure and biology of cathelicidins. Adv Exp Med
Biol. 479:203–218. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zanetti M: The role of cathelicidins in
the innate host defenses of mammals. Curr Issues Mol Biol.
7:179–196. 2005.PubMed/NCBI
|
|
3
|
Cowland JB, Johnsen AH and Borregaard N:
hCAP-18, a cathelin/pro-bactenecin-like protein of human neutrophil
specific granules. FEBS Lett. 368:173–176. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sorensen O, Arnljots K, Cowland JB,
Bainton DF and Borregaard N: The human antibacterial cathelicidin,
hCAP-18, is synthesized in myelocytes and metamyelocytes and
localized to specific granules in neutrophils. Blood. 90:2796–2803.
1997.PubMed/NCBI
|
|
5
|
Agerberth B, Gunne H, Odeberg J, Kogner P,
Boman HG and Gudmundsson GH: FALL-39, a putative human peptide
antibiotic, is cysteine-free and expressed in bone marrow and
testis. Proc Natl Acad Sci USA. 92:195–199. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Frohm M, Agerberth B, Ahangari G, et al:
The expression of the gene coding for the antibacterial peptide
LL-37 is induced in human keratinocytes during inflammatory
disorders. J Biol Chem. 272:15258–15263. 1997. View Article : Google Scholar
|
|
7
|
Chen PH and Fang SY: The expression of
human antimicrobial peptide LL-37 in the human nasal mucosa. Am J
Rhinol. 18:381–385. 2004.PubMed/NCBI
|
|
8
|
Murakami M, Ohtake T, Dorschner RA and
Gallo RL: Cathelicidin antimicrobial peptides are expressed in
salivary glands and saliva. J Dent Res. 81:845–850. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bals R, Wang X, Zasloff M and Wilson JM:
The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of
the human lung where it has broad antimicrobial activity at the
airway surface. Proc Natl Acad Sci USA. 95:9541–9546. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Okumura K, Itoh A, Isogai E, et al:
C-terminal domain of human CAP18 antimicrobial peptide induces
apoptosis in oral squamous cell carcinoma SAS-H1 cells. Cancer
Lett. 212:185–194. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Henzler Wildman KA, Lee DK and Ramamoorthy
A: Mechanism of lipid bilayer disruption by the human antimicrobial
peptide, LL-37. Biochemistry. 42:6545–6558. 2003.PubMed/NCBI
|
|
12
|
Zasloff M: Antimicrobial peptides of
multicellular organisms. Nature. 415:389–395. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Van Cutsem E and Geboes K: The
multidisciplinary management of gastrointestinal cancer. The
integration of cytotoxics and biologicals in the treatment of
metastatic colorectal cancer. Best Pract Res Clin Gastroenterol.
21:1089–1108. 2007.PubMed/NCBI
|
|
14
|
Li Z, Song H, He W, Tian Y and Huang T: In
vitro chemosensitivity testing of primary and recurrent breast
carcinomas and its clinical significance. J Huazhong Univ Sci
Technolog Med Sci. 28:683–687. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yanagawa E, Nishiyama M, Saeki T, et al:
Chemosensitivity tests in colorectal cancer patients. Jpn J Surg.
19:432–438. 1989. View Article : Google Scholar
|
|
16
|
Lane DP and Lain S: Therapeutic
exploitation of the p53 pathway. Trends Mol Med. 8:S38–S42. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Bunz F, Dutriaux A, Lengauer C, et al:
Requirement for p53 and p21 to sustain G2 arrest after DNA damage.
Science. 282:1497–1501. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Johansson J, Gudmundsson GH, Rottenberg
ME, Berndt KD and Agerberth B: Conformation-dependent antibacterial
activity of the naturally occurring human peptide LL-37. J Biol
Chem. 273:3718–3724. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zamzami N, Marchetti P, Castedo M, et al:
Sequential reduction of mitochondrial transmembrane potential and
generation of reactive oxygen species in early programmed cell
death. J Exp Med. 182:367–377. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Watanabe I, Toyoda M, Okuda J, et al:
Detection of apoptotic cells in human colorectal cancer by two
different in situ methods: antibody against single-stranded DNA and
terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick
end-labeling (TUNEL) methods. Jpn J Cancer Res. 90:188–193. 1999.
View Article : Google Scholar
|
|
21
|
Aarbiou J, Ertmann M, van Wetering S, et
al: Human neutrophil defensins induce lung epithelial cell
proliferation in vitro. J Leukoc Biol. 72:167–174. 2002.PubMed/NCBI
|
|
22
|
Risso A, Braidot E, Sordano MC, et al:
BMAP-28, an antibiotic peptide of innate immunity, induces cell
death through opening of the mitochondrial permeability transition
pore. Mol Cell Biol. 22:1926–1935. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Risso A, Zanetti M and Gennaro R:
Cytotoxicity and apoptosis mediated by two peptides of innate
immunity. Cell Immunol. 189:107–115. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Utsugi T, Schroit AJ, Connor J, Bucana CD
and Fidler IJ: Elevated expression of phosphatidylserine in the
outer membrane leaflet of human tumor cells and recognition by
activated human blood monocytes. Cancer Res. 51:3062–3066.
1991.PubMed/NCBI
|
|
25
|
Van Blitterswijk WJ, De Veer G, Krol JH
and Emmelot P: Comparative lipid analysis of purified plasma
membranes and shed extracellular membrane vesicles from normal
murine thymocytes and leukemic GRSL cells. Biochim Biophys Acta.
688:495–504. 1982.
|
|
26
|
Morgan SE and Kastan MB: p53 and ATM: cell
cycle, cell death, and cancer. Adv Cancer Res. 71:1–25. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Westphal CH: Cell-cycle signaling: Atm
displays its many talents. Curr Biol. 7:R789–R792. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lowe SW and Sherr CJ: Tumor suppression by
Ink4a-Arf: progress and puzzles. Curr Opin Genet Dev. 13:77–83.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Vousden KH and Lu X: Live or let die: the
cell’s response to p53. Nat Rev Cancer. 2:594–604. 2002.
|
|
30
|
Miyanoshita A, Hara S, Sugiyama M, et al:
Isolation and characterization of a new member of the insect
defensin family from a beetle, Allomyrina dichotoma. Biochem
Biophys Res Commun. 220:526–531. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nagaoka I, Hirota S, Yomogida S, Ohwada A
and Hirata M: Synergistic actions of antibacterial neutrophil
defensins and cathelicidins. Inflamm Res. 49:73–79. 2000.
View Article : Google Scholar : PubMed/NCBI
|
